TherapeuticsMD (TXMD) Interest & Investment Income (2014 - 2026)
TherapeuticsMD's (TXMD) quarterly Interest & Investment Income came in at $69000.0 in Q2 2026, up 137.93% on a YoY basis from $29000.0 in Q2 2025, and up 68.29% quarter-over-quarter from $41000.0 in Q1 2026.
Powered by 
Analysis
TherapeuticsMD (TXMD) Interest & Investment Income (2014 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has reported Interest & Investment Income for 6 consecutive years, with $69000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest & Investment Income rose 137.93% year-over-year to $69000.0; the trailing twelve-month figure through Jun 2026 stood at $168000.0 (up 189.66% YoY), and the FY2025 full-year result was $142000.0, up 5.19% from the prior year.
- Interest & Investment Income climbed to $69000.0 in Q2 2026 per TXMD's latest filing, from $41000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $69000.0 in Q2 2026 and bottomed at $29000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 89.50 Mn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 35.58 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 27.90 Mn |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | 69,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69,000.00 |
| Mar 31, 2026 | 41,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Jun 30, 2017 | 3,832.00 |
| Mar 31, 2017 | 3,867.00 |
| Jun 30, 2016 | 2,863.00 |
| Mar 31, 2016 | 2,536.00 |
| Dec 31, 2015 | -6,111.00 |
| Sep 30, 2015 | 2,760.00 |
| Mar 31, 2015 | 18,513.00 |
| Dec 31, 2014 | 9,553.00 |
| Sep 30, 2014 | 9,364.00 |